Prevention Trial to Achieve Cardiovascular Targets

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Coronary Artery DiseasePeripheral Arterial DiseaseHyperlipidemiaHypertensionDiabetesPrediabetesObesity
Interventions
BEHAVIORAL

Prevention Consult

In addition to usual care, patients will receive a prevention consult by a prevention fellow and attending following their intervention. The consult will include guideline based medical recommendations for optimization of the patient's medical regimen targeting dyslipidemia, hypertension and diabetes. In addition, each patient will be educated on the cardiovascular disease process and given detailed lifestyle recommendations on physical activity, improved nutrition, smoking cessation and medication adherence.

BEHAVIORAL

Consult & Behavioral Intervention

In addition to usual care and prevention consult (as detailed above), patients will receive a full motivational intervention program by a trained motivational coach and text messages over 6 months.

Trial Locations (1)

10016

New York University Langone Medical Center, New York

All Listed Sponsors
collaborator

The Rainer Arnhold Foundation

UNKNOWN

lead

NYU Langone Health

OTHER

NCT01642355 - Prevention Trial to Achieve Cardiovascular Targets | Biotech Hunter | Biotech Hunter